thiophenes has been researched along with Kidney Diseases in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.50) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 11 (27.50) | 29.6817 |
| 2010's | 19 (47.50) | 24.3611 |
| 2020's | 5 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Dong, D; Lu, D; Wang, Y; Wang, Z; Wu, B; Wu, Z; Yu, P | 1 |
| Chen, YY; He, LY; Hong, H; Lei, YT; Yang, YY; Zou, J | 1 |
| Chan, JSD; Chang, SY; Chenier, I; El-Mortada, MA; Ingelfinger, JR; Liao, MC; Lo, CS; Miyata, KN; Peng, J; Yamashita, M; Zhang, SL; Zhao, XP | 1 |
| Gaikwad, AB; Sharma, N | 1 |
| Chambers, C; Giani, J; Sawyer, MB | 1 |
| Maegawa, H; Nakamura, I; Tabuchi, H; Tobe, K; Uno, S | 2 |
| Kanasaki, K; Kitada, M; Koya, D; Li, J; Nitta, K; Takagaki, Y; Takagi, S; Takasu, T | 1 |
| Chana, F; Llau, JV; Marco, P; Zamorano, JL | 1 |
| Ha, H; Hwang, I; Jeong, LS; Lee, HW; Lee, J; Lee, JH | 1 |
| Bajorek, B; Wang, Y | 1 |
| Gosch, M; Kammerlander, C; Nicholas, JA | 1 |
| Curnow, J; Joseph, J; McLintock, C; McRae, S; Nandurkar, H; Tran, H; Wood, P; Young, L | 1 |
| Elkady, AA; Ibrahim, IM | 1 |
| Armağan, A; Dönmezs, S; Kirbas, A; Öktem, F; Silay, MS; Sirmali, M; Sirmali, R; Uz, E; Yilmaz, HR | 1 |
| Lane, DA; Wood, K | 1 |
| Blankestijn, PJ; Rupp, H | 1 |
| Borel, AG; Brandt, JT; Ernest, CS; Farid, NA; Kles, KA; Li, YG; Ni, L; Payne, CD; Salazar, DE; Small, DS; Winters, KJ; Wrishko, RE | 1 |
| Kim, HS; Kim, MC; Lee, JY; Park, CS | 1 |
| Eikelboom, JW; Weitz, JI | 1 |
| Huisman, MV; Kooiman, J; van de Peppel, WR; van der Meer, FJ | 1 |
| Arica, V; Basarslan, F; Nacar, A; Nacar, E; Tutanc, M; Tutanc, OD; Yılmaz, N; Zararsiz, I | 1 |
| Barton, M | 1 |
| Basra, SS; Lakkis, NM; Tsai, P | 1 |
| Bortolatto, CF; Chagas, PM; Nogueira, CW; Wilhelm, EA | 1 |
| Baker, RA; Bennetts, JS; Cardinal, T; Tully, PJ | 1 |
| Terra, SG | 1 |
| Arslan, MK; Candir, O; Ciris, M; Oktem, F; Ozguner, F; Uz, E; Yilmaz, HR | 1 |
| Erdogan, H; Fadillioglu, E; Irmak, MK; Uçar, M; Yagmurca, M | 1 |
| Akcay, A; Bayrak, R; Isik, B; Sogut, S | 1 |
| Coyne, T; Dhaun, N; Goddard, J; Kramer, W; Melville, V; Stavros, F; Swan, S; Webb, DJ | 1 |
| Ram, CV | 1 |
| Branten, AJ; Hilbrands, LB; Huysmans, FT; Koene, RA; van Hamersvelt, HW | 1 |
| Brooks, DP; Contino, LC; Grygielko, E; Laping, NJ; Olson, BA; Wong, VY | 1 |
| Ramahi, TM | 1 |
| Abrahamsen, CT; Barone, FC; Brooks, DP; Campbell, WG; Contino, LC; Edwards, RM; Grygielko, ET; Laping, NJ; Nelson, AH; Pullen, MA | 1 |
| McMurtry, RJ; Mitchell, JR | 1 |
| Bensted, JP; Calvert, AH; Clinton, S; Hughes, LR; Jodrell, DI; Morgan, SE; Newell, DR | 1 |
| Morin, D; Renouard, A; Rocher, I; Tillement, JP; Urien, S | 1 |
| Bodey, GP; Inagaki, J; Rodriguez, V | 1 |
8 review(s) available for thiophenes and Kidney Diseases
| Article | Year |
|---|---|
[New clinical perspectives in the management of oral direct anticoagulant agents].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Elective Surgical Procedures; Emergencies; Factor Xa Inhibitors; Hemorrhage; Humans; Kidney Diseases; Morpholines; Orthopedic Procedures; Postoperative Complications; Premedication; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk; Rivaroxaban; Thiophenes; Thrombophilia; Vitamin K | 2014 |
New oral anticoagulants in practice: pharmacological and practical considerations.
Topics: Administration, Oral; Aging; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Complementary Therapies; Dabigatran; Drug Interactions; Drug Monitoring; Humans; International Normalized Ratio; Kidney Diseases; Liver Diseases; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Sex Factors; Stroke; Thiophenes; Warfarin | 2014 |
Treatment of osteoporosis in older adults.
Topics: Aged; Aging; Antibodies, Monoclonal, Humanized; Bone Density; Denosumab; Diphosphonates; Female; Frail Elderly; Hormone Replacement Therapy; Humans; Kidney Diseases; Male; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Teriparatide; Thiophenes | 2014 |
Clinical profile of eprosartan: a different angiotensin II receptor blocker.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Humans; Hypertension; Imidazoles; Kidney Diseases; Renin-Angiotensin System; Sympathetic Nervous System; Thiophenes | 2008 |
Endothelin antagonism and reversal of proteinuric renal disease in humans.
Topics: Endothelins; Humans; Isoxazoles; Kidney Diseases; Phenylpropionates; Proteinuria; Pyridines; Pyrimidines; Receptor, Endothelin A; Thiophenes | 2011 |
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine; Uremia | 2011 |
Angiotensin blockade with eprosartan: vascular and functional implications.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atherosclerosis; Humans; Imidazoles; Kidney Diseases; Platelet Aggregation; Renin-Angiotensin System; Sympathetic Nervous System; Thiophenes; Ventricular Dysfunction, Left | 2007 |
Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Cardiovascular Diseases; Humans; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Metabolic Clearance Rate; Patient Selection; Renin-Angiotensin System; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Valine; Valsartan | 2001 |
1 trial(s) available for thiophenes and Kidney Diseases
| Article | Year |
|---|---|
Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cross-Over Studies; Cyclosporine; Female; Glomerulonephritis; Hemodynamics; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Propanolamines; Renal Circulation; Thiophenes | 1998 |
31 other study(ies) available for thiophenes and Kidney Diseases
| Article | Year |
|---|---|
Involvement of REV-ERBα dysregulation and ferroptosis in aristolochic acid I-induced renal injury.
Topics: Animals; Aristolochic Acids; Cell Line; Cell Survival; Epithelial Cells; Ferroptosis; Gene Expression Regulation; Humans; Isoquinolines; Kidney Diseases; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Nuclear Receptor Subfamily 1, Group D, Member 1; Thiophenes | 2021 |
IκB kinase promotes Nrf2 ubiquitination and degradation by phosphorylating cylindromatosis, aggravating oxidative stress injury in obesity-related nephropathy.
Topics: Amides; Animals; Cell Line; Deubiquitinating Enzyme CYLD; Humans; I-kappa B Kinase; Kidney; Kidney Diseases; Lipid Metabolism; Lipoproteins, LDL; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Obesity; Oxidative Stress; Oxidoreductases; Phosphorylation; Protein Kinase Inhibitors; Reactive Oxygen Species; Thiophenes; Ubiquitination | 2021 |
Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Topics: Angiotensin II; Animals; Cathepsin L; Glomerulosclerosis, Focal Segmental; Imidazoles; Kidney Diseases; Male; Mice; Mice, Knockout; Podocytes; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2022 |
Effects of renal ischemia injury on brain in diabetic and non-diabetic rats: Role of angiotensin II type 2 receptor and angiotensin-converting enzyme 2.
Topics: Angiotensin-Converting Enzyme 2; Animals; Brain; Diabetes Mellitus, Experimental; Diminazene; Hyperglycemia; Imidazoles; Kidney Diseases; Kidney Tubules; Male; Malondialdehyde; Nitrites; Rats, Wistar; Receptor, Angiotensin, Type 2; Reperfusion Injury; Sulfonamides; Thiophenes | 2020 |
Tolerability of pemetrexed and oxaliplatin in the treatment of stage III colon cancer during raltitrexed shortage.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Canada; Colonic Neoplasms; Female; Humans; Kidney Diseases; Middle Aged; Oxaliplatin; Pemetrexed; Quinazolines; Thiophenes; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Heart Rate; Humans; Hypoglycemic Agents; Japan; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Product Surveillance, Postmarketing; Registries; Thiophenes; Treatment Outcome; Triglycerides | 2018 |
Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet.
Topics: Animals; Diet, High-Fat; Energy Intake; Glucosides; Kidney Diseases; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mitochondria; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2018 |
Safety and efficacy of ipragliflozin in elderly versus non-elderly Japanese patients with type 2 diabetes mellitus: a subgroup analysis of the STELLA-LONG TERM study.
Topics: Aged; Asian People; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Japan; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Skin Diseases; Thiophenes; Treatment Outcome | 2018 |
The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Animals; Collagen Type I; Epithelial-Mesenchymal Transition; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Fibrosis; Gene Expression Regulation; JNK Mitogen-Activated Protein Kinases; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Protein-Lysine 6-Oxidase; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3; RNA, Messenger; Signal Transduction; Smad Proteins; Thiophenes; Transforming Growth Factor beta1; Ureteral Obstruction | 2013 |
New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Blood Loss, Surgical; Contraindications; Dabigatran; Drug Interactions; Drug Monitoring; Drug Substitution; Elective Surgical Procedures; Emergencies; Hematoma, Epidural, Spinal; Hemorrhage; Humans; Kidney Diseases; Liver Diseases; Morpholines; Patient Selection; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thrombophilia | 2014 |
Protective effects of erdosteine against nephrotoxicity caused by gamma radiation in male albino rats.
Topics: Animals; Cytokines; Expectorants; Gamma Rays; Gene Expression Regulation; Kidney Diseases; Male; Rats; Thioglycolates; Thiophenes | 2016 |
Protective effects of erdosteine, vitamin E, and vitamin C on renal injury induced by the ischemia-reperfusion of the hind limbs in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Hindlimb; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Oxidoreductases; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thioglycolates; Thiophenes; Vitamin E | 2015 |
Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Interactions; Drug Monitoring; Drug Substitution; Female; Hemorrhage; Humans; Kidney Diseases; Kidney Function Tests; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombophilia | 2015 |
Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease.
Topics: Adult; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Protein Binding; Thiophenes | 2009 |
Erdosteine in renal ischemia-reperfusion injury: an experimental study in pigs.
Topics: Animals; Antioxidants; Free Radical Scavengers; Kidney; Kidney Diseases; Male; Reperfusion Injury; Swine; Swine Diseases; Thioglycolates; Thiophenes | 2010 |
New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty.
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Drug Interactions; Hemorrhage; Humans; Kidney Diseases; Morpholines; Pyridines; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism | 2011 |
Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs.
Topics: Administration, Oral; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biomarkers; Chronic Disease; Creatinine; Dabigatran; Fibrinolytic Agents; Glomerular Filtration Rate; Humans; Incidence; Kidney; Kidney Diseases; Morpholines; Netherlands; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Severity of Illness Index; Thiophenes | 2011 |
Effects of erdosteine on cyclosporin-A-induced nephrotoxicity.
Topics: Animals; Antioxidants; Catalase; Cyclosporine; Glutathione Peroxidase; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thioglycolates; Thiophenes | 2012 |
High doses of 2,2'-dithienyl diselenide cause systemic toxicity in rats: an in vitro and in vivo study.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain; Catalase; Chemical and Drug Induced Liver Injury; Chlorides; Drinking; Eating; Enzyme Inhibitors; Female; Glutathione; Kidney Diseases; Lipid Peroxidation; Male; Organoselenium Compounds; Oxidoreductases Acting on Sulfur Group Donors; Porphobilinogen Synthase; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Thiophenes; Weight Gain; Zinc Compounds | 2013 |
Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
Topics: Aged; Aged, 80 and over; Australia; Coronary Artery Bypass; Coronary Artery Disease; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Hospital Mortality; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Hemorrhage; Proportional Hazards Models; Renal Dialysis; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2012 |
Cardiology patient page. Angiotensin receptor blockers.
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diuretics; Dizziness; Drug Combinations; Drug Interactions; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Olmesartan Medoxomil; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2003 |
In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Topics: Acetylglucosaminidase; Administration, Oral; Animals; Anti-Bacterial Agents; Catalase; Disease Models, Animal; Drug Antagonism; Drug Therapy, Combination; Injections, Intraperitoneal; Kidney; Kidney Diseases; Kidney Tubules; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Thioglycolates; Thiophenes; Vancomycin | 2005 |
Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Free Radical Scavengers; Kidney Diseases; Kidney Tubules; Lipid Peroxidation; Male; Oxidation-Reduction; Oxidative Stress; Proteins; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thioglycolates; Thiophenes | 2006 |
Erdosteine against acetaminophen induced renal toxicity.
Topics: Acetaminophen; Animals; Drug Evaluation, Preclinical; Female; Kidney; Kidney Cortex; Kidney Diseases; Kidney Tubules, Proximal; Lipid Peroxidation; Nitric Oxide; Rats; Rats, Wistar; Thioglycolates; Thiophenes | 2006 |
The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairment.
Topics: Adolescent; Adult; Aged; Endothelin A Receptor Antagonists; Female; Humans; Isoxazoles; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Receptor, Endothelin A; Thiophenes | 2007 |
Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartan.
Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Gene Expression Regulation; Hypertension; Imidazoles; Kidney Diseases; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Thiophenes | 2000 |
The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension.
Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Blotting, Western; Body Weight; Dietary Fats; Disease Progression; Extracellular Matrix; Fibrinolysin; Gene Expression Regulation; Heart Rate; Hypertension; Imidazoles; Kidney Diseases; Male; Organ Size; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Serine Proteinase Inhibitors; Sodium Chloride, Dietary; Stroke; Thiophenes; Thrombosis | 2002 |
Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine.
Topics: Animals; Cephaloridine; Chemical and Drug Induced Liver Injury; Furans; Furosemide; In Vitro Techniques; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Mice; Microsomes; Necrosis; Thiophenes | 1977 |
The renal effects of N10-propargyl-5,8-dideazafolic acid (CB3717) and a non-nephrotoxic analogue ICI D1694, in mice.
Topics: Animals; Carbon Radioisotopes; Cisplatin; Creatinine; Female; Folic Acid; Glomerular Filtration Rate; Inulin; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Quinazolines; Thiophenes; Thymidylate Synthase; Urea | 1991 |
Variation in serum binding of tertatolol mediated by disease-induced modification of alpha-acid glycoprotein concentration.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Blood Proteins; Fatty Acids, Nonesterified; Female; Humans; Inflammation; Kidney Diseases; Liver Diseases; Male; Middle Aged; Orosomucoid; Propanolamines; Protein Binding; Thiophenes | 1988 |
Clinical pharmacology of ticarcillin (alpha-carboxyl-3-thienylmethyl penicillin, BRL-2288).
Topics: Adolescent; Adult; Aged; Carboxylic Acids; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Diseases; Leukemia; Middle Aged; Neoplasms; Penicillins; Thiophenes; Time Factors | 1973 |